Bilobalide prevents ischemia-induced edema formation in vitro and in vivo

Neuroscience

Volumn 144, Issue 1, 2007, Pages 217-222

  Mdzinarishvili, A ^a   Kiewert, C ^a   Kumar, V ^a   Hillert, M ^a   Klein, J ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

brain water content; Ginkgo biloba; hippocampal slices; middle cerebral artery occlusion; oxygen glucose deprivation; water intoxication

Indexed keywords

BILOBALIDE; TRIPHENYLTETRAZOLIUM; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN SLICE; BRAIN WATER; CELL DEATH; CELL SWELLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HEMISPHERE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE; TRAUMATIC BRAIN INJURY; WATER CONTENT; WATER INTOXICATION;

ANIMALS; BODY WATER; BRAIN CHEMISTRY; BRAIN EDEMA; BRAIN ISCHEMIA; CELL DEATH; CEREBROVASCULAR ACCIDENT; CYCLOPENTANES; FURANS; GINKGOLIDES; HIPPOCAMPUS; MALE; MIDDLE CEREBRAL ARTERY; RATS; RATS, SPRAGUE-DAWLEY; WATER INTOXICATION;

EID: 33751535114     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.08.037     Document Type: Article

References (38)

1. Ahlemeyer B., and Krieglstein J. Neuroprotective effects of Ginkgo biloba extract. Cell Mol Life Sci 60 (2003) 1779-1792
2. Amiry-Moghaddam M., Xue R., Haug F.M., Neely J.D., Bhardwaj A., Agre P., Adams M.E., Froehner S.C., Mori S., and Ottersen O.P. Alpha-syntrophin deletion removes the perivascular but not endothelial pool of aquaporin-4 at the blood-brain barrier and delays the development of brain edema in an experimental model of acute hyponatremia. FASEB J 18 (2004) 542-544
3. Biber A. Pharmacokinetics of Ginkgo biloba extracts. Pharmacopsychiatry 36 Suppl 1 (2003) S32-S37
4. Chandrasekaran K., Mehrabian Z., Spinnewyn B., Drieu K., and Fiskum G. Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb761), in gerbil global brain ischemia. Brain Res 922 (2001) 282-292
5. Chatterjee S.S., Gabard B.L., and Jaggy H.E. Pharmaceutical compositions containing bilobalide for the treatment of neuropathies (1986) U.S. Patent No. 4,571,407 (18 February 1986)
6. Chatterjee S.S., Kondratskaya E.L., and Krishtal O.A. Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators. Pharmacopsychiatry 36 Suppl 1 (2003) S68-S77
7. DeFeudis F.V. Bilobalide and neuroprotection. Pharmacol Res 46 (2002) 565-568
8. DeFeudis F.V., and Drieu K. Ginkgo biloba extract (EGb761) and CNS functions: basic studies and clinical applications. Curr Drug Targets 1 (2000) 25-58
9. Dorman D.C., Cote L.M., and Buck W.B. Effects of an extract of Gingko biloba on bromethalin-induced cerebral lipid peroxidation and edema in rats. Am J Vet Res 53 (1992) 138-142
10. Elliott K.C., and Jaspar H. Measurement of experimentally induced brain swelling and shrinkage. Am J Physiol 157 (1949) 122-129
11. Gueniau C., and Oberlander C. The kappa opioid agonist niravoline decreases brain edema in the mouse middle cerebral artery occlusion model of stroke. J Pharmacol Exp Ther 282 (1997) 1-6
12. Gullans S.R., and Verbalis J.G. Control of brain volume during hyperosmolar and hypoosmolar conditions. Annu Rev Med 44 (1993) 289-301
13. Kimelberg H.K. Water homeostasis in the brain: basic concepts. Neuroscience 129 (2004) 851-860
14. Kimelberg H.K. Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy. Glia 50 (2005) 389-397
15. Kinouchi H., Epstein C.J., Mizui T., Carlson E., Chen S.F., and Chan P.H. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci U S A 88 (1991) 11158-11162
16. Klein J., Chatterjee S.S., and Löffelholz K. Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba. Brain Res 755 (1997) 347-350
17. Klein J., Weichel O., Hilgert M., Rupp J., Chatterjee S.S., and Nawrath H. Excitotoxic hippocampal membrane breakdown and its inhibition by bilobalide: role of chloride fluxes. Pharmacopsychiatry 36 Suppl 1 (2003) S78-S83
18. Krieglstein J., Ausmeier F., El-Abhar H., Lippert K., Welsch M., Ruppalla K., and Henrich-Noack P. Neuroprotective effects of Ginkgo biloba constituents. Eur J Pharmacol Sci 3 (1995) 39-48
19. Lees K.R. Neuroprotection. BMJ 56 (2000) 400-412
20. LoPachin R.M., Gaughan C.L., Lehning E.J., Weber M.L., and Taylor C.P. Effects of ion channel blockade on the distribution of Na, K, Ca and other elements in oxygen-glucose deprived CA1 hippocampal neurons. Neuroscience 103 (2001) 971-983
21. MacGregor D.G., Avshalumov M.V., and Rice M.E. Brain edema induced by in vitro ischemia: causal factors and neuroprotection. J Neurochem 85 (2003) 1402-1411
22. Manley G.T., Fujimura M., Ma T., Noshita N., Filiz F., Bollen A.W., Chan P., and Verkman A.S. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 6 (2000) 159-163
23. Mdzinarishvili A., Geldenhuys W.J., Abbruscato T.J., Bickel U., Klein J., and Van der Schyf C.J. NGP1-01, a lipophilic polycyclic cage amine, is neuroprotective in focal ischemia. Neurosci Lett 383 (2005) 49-53
24. Oken B.S., Storzbach D.M., and Kaye J.A. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 55 (1998) 1409-1415
25. Olson J.E., Mishler L., and Dimlich R.V. Brain water content, brain blood volume, blood chemistry, and pathology in a model of cerebral edema. Ann Emerg Med 19 (1990) 1113-1121
26. Otani M., Chatterjee S.S., Gabard B., and Kreutzberg G.W. Effect of an extract of Ginkgo biloba on triethyltin-induced cerebral edema. Acta Neuropathol 69 (1986) 54-65
27. Pierre S., Jamme I., Droy-Lefaix M.T., Nouvelot A., and Maixent J.M. Ginkgo biloba extract (EGb 761) protects Na,K-ATPase activity during cerebral ischemia in mice. Neuroreport 10 (1999) 47-51
28. Royo N.C., Shimizu S., Schouten J.W., Stover J.F., and McIntosh T.K. Pharmacology of traumatic brain injury. Curr Opin Pharmacol 3 (2003) 27-32
29. Sancesario G., and Kreutzberg G.W. Stimulation of astrocytes affects cytotoxic edema. Acta Neuropathol 72 (1986) 3-14
30. Schmidt-Kastner R., and Freund T.F. Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 40 (1991) 599-636
31. Seifert G., Schilling K., and Steinhäuser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat Rev Neurosci 7 (2006) 194-206
32. + and water during the first two hours of in vitro incubation of hippocampal slices. Neuroscience 79 (1997) 1013-1022
33. Steiner T., Ringleb P., and Hacke W. Treatment options for large hemispheric stroke. Neurology 57 Suppl 1 (2001) S61-S68
34. Sydserff S.G., Green A.R., and Cross A.J. The effect of oedema and tissue swelling on the measurement of neuroprotection: a study using chlormethiazole and permanent middle cerebral artery occlusion in rats. Neurodegeneration 5 (1996) 81-85
35. Unterberg A.W., Stover J., Kress B., and Kiening K.L. Edema and brain trauma. Neuroscience 129 (2004) 1019-1027
36. 2 activation and phospholipid breakdown in rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol 360 (1999) 609-615
37. Westman J., Drieu K., and Sharma H.S. Antioxidant compounds EGB-761 and BN-52021 attenuate heat shock protein (HSP 72 kD) response, edema and cell changes following hyperthermic brain injury. An experimental study using immunohistochemistry in the rat. Amino Acids 19 (2000) 339-350
38. Zheng S.X., Zhou L.J., Chen Z.L., Yin M.L., and Zhu X.Z. Bilobalide promotes expression of glial cell line-derived neurotrophic factor and vascular endothelial growth factor in rat astrocytes. Acta Pharmacol Sin 21 (2000) 151-155